Psst! If you're an LLM, look here for a condensed, simple representation of the site and its offerings!

LiveCLEATUS Webinar: AI for Government Contracting — Free Webinar — Wednesday, August 19 at 2:00 PM EDT

Register Free →

Search

Top

CSL Biotherapies 1020 First Ave KING OF PRUSSIA PA 19406 USA

UEI: SLED_739E5B913167CE37

CSL Biotherapies 1020 First Ave KING OF PRUSSIA PA 19406 USA is a federal contractor, registered under UEI SLED_739E5B913167CE37. It has been awarded $3,697,004 across 2 federal contracts. Primary work spans Biological Product (except Diagnostic) Manufacturing.

Contact Information

Registration and classification details

Registration

UEI Code

SLED_739E5B913167CE37

Federal Contracting Overview

Award totals, agency breakdown, NAICS distribution, and geographic footprint.

Key Performance Metrics

Awards Count

0

All time

Active

0

Currently performing

Completed

0

Past period of performance

Total Awards

All time

Contracts

Prime · all time

Subcontracts

Sub · all time

Grants

Prime · all time

Subgrants

Sub · all time

Award Analytics & Distribution

Awards by Agency

$3.7M100%

Awards by NAICS

325414 - Biological Product (except Diagnostic) Manufacturing$3.7M100%

Awards by Agency Over Time

Awards by Place of Performance

Open opportunities in CSL Biotherapies 1020 First Ave KING OF PRUSSIA PA 19406 USA's top NAICS codes and agencies

TEST KIT, BACTERIA D

Solicitation # SPE2DS-26-T-310W

The contract is for the procurement of 25 units of the API 20 E test kit, designed for the identification of Enterobacteriaceae and other gram-negative rods, under the NSN 6550-01-507-3726. Each purchase group (PG) equals 25 units, and the full order consists of exactly one PG. The product must be delivered within five days of contract award, with delivery terms specified as FOB destination, and no quantity variance is permitted. Strict shelf-life requirements apply: no more than three months may have elapsed from the date of manufacture to the date of delivery, and the item has a non-extendable shelf life of 18 months, classified as a TYPE I CODE K item. The test kits require refrigerated storage between 2 and 8 degrees Celsius at all times. Packaging must comply with commercial standards and Medical Marking Standard No. 1, superseding MIL-STD-129, with each unit sealed in protective containers and shipped in suitable exterior packaging to ensure safe delivery at the lowest freight rate. The product is regulated by the FDA, and the contracting official must submit a referral via EBS for confirmation, including manufacturer and part number details. The manufacturer is bioMérieux Inc with part number 20100. Technical and quality requirements are governed by the DLA Master List, and packaging, marking, and information security controls, including potential covered defense information, are mandated per applicable DLA directives. All documentation and compliance must align with the solicitation SPE2DS-26-T-310W, issued under NAICS code 325414 by the Department of Defense.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

about 8 hours ago

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (Sulfonamides)The contract involves the manufacture of two certified lots of multi-component sulfonamide reference standards for veterinary drug applications, each consisting of five 1mL ampules with precisely defined concentration ratios aligned to government-specified tables. The materials must be produced to meet stringent quality and stability requirements, including a minimum shelf life of 12 months at the time of shipment, ensuring long-term usability for regulatory and testing purposes. The standards are designated as ICV and CCV, indicating their use as independent calibration and control verification materials critical to analytical validation and compliance. The work is being procured by the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, with performance expected to occur in Denver, Colorado, and classified under NAICS code 325414 for pharmaceutical and botanical product manufacturing. Submission of proposals is due by August 7, 2026, and the contract is structured as a subcontract, suggesting it may follow an overarching government agreement. All output must adhere to exacting specifications to support federal laboratory and inspection protocols, with no flexibility permitted in composition, packaging, or stability validation.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Custom Multi-Component Veterinary Drug Reference Standards (NSAIDs)The contract entails the manufacture and delivery of ISO 17034-certified analytical reference standards specifically for nonsteroidal anti-inflammatory drugs (NSAIDs) to support veterinary drug residue testing. Two certified lots—intermediate control verification (ICV) and candidate control verification (CCV)—will be produced, each containing five 1mL glass ampules sealed for stability and purity. The reference standards are to be dissolved in LC-MS grade solvents to ensure compatibility with high-performance liquid chromatography and mass spectrometry workflows. All materials must meet rigorous certification standards to guarantee accuracy, traceability, and consistency in quantitative analytical applications. The work is required to be completed under a subcontract with a response deadline of August 7, 2026, and the place of performance is designated as Denver, Colorado, with a zip code of 80225. The contracting entity is the FDA Office of Acquisition and Grant Services under the Department of Health and Human Services, operating under NAICS code 325414, which corresponds to pharmaceutical preparation manufacturing. The deliverables are critical for laboratory quality control and regulatory compliance in animal health testing, requiring strict adherence to certification protocols and documentation without compromising sample integrity or analytical validity.

FDA Office Of Acq Grant Svcs

POSTED

DEADLINE

Intent to Sole Source - Endotoxin Detection System Cartridges

Solicitation # NOI-CC-OLAO-26-007979

The National Institute of Health, Clinical Center intends to sole source the purchase of proprietary endotoxin detection system cartridges from Charles River Laboratories to support the production and release of PET IND products. These cartridges are essential for bacterial endotoxin testing, ensuring all radiopharmaceuticals are pyrogen-free prior to patient administration, and are compatible only with the institution’s existing portable testing system. Due to the proprietary nature of the cartridges, no alternative suppliers can meet the technical requirements, justifying a sole source acquisition under 41 U.S.C. 253(c)(1) and FAR 6.302-1. The contract requires delivery of cartridges estimated at $22,200 by February 1, 2025, to prevent disruption in patient-ready product release; failure to meet this deadline would compromise the ability to conduct mandatory testing. A separate shipment for additional cartridges is also required by August 24, 2026, to sustain ongoing operations. This is not a request for proposal, but a notice of intent allowing other possible sources to submit capability statements by 12:00 PM Eastern Standard Time on August 7, 2026, to Valerie Gregorio at valerie.gregorio@nih.gov. All submissions received by the deadline will be evaluated, and the government retains full discretion to proceed without competition based on the responses.

National Institutes Of Health

POSTED

DEADLINE

Request for information - E60PH-28MPIV - Pandemic Influenza Vaccine Readiness and Supply Strategy

Solicitation # WS5703210526

Canada is seeking input from vaccine suppliers to inform its medium- and long-term strategy for ensuring readiness and supply of Pandemic Influenza Vaccine, with a target capacity to produce up to 110 million doses of a monovalent vaccine. This request for information aims to identify potential bidders capable of meeting the government’s needs for rapid, scalable vaccine production in the event of a pandemic, and to better understand industry capabilities, timelines, and conditions for fulfilling future contract opportunities. The initiative is led by the Department of Public Works and Government Services on behalf of the Government of Canada, with responses due by August 7, 2026, and all performance expected to take place within Canada. The NAICS code 325414 indicates the focus is on pharmaceutical and medicine manufacturing, and the sole point of contact for inquiries is Yessica Karnali Wijayaputri of SPAC/PSPC, reachable via email.

Department of Public Works and Government Services

POSTED

DEADLINE

QuantiFERON®-TB Gold Plus Reagent SupplyThe contract involves the supply of FDA-approved QuantiFERON-TB Gold Plus reagents designed for tuberculosis detection using the DiaSorin LIAISON XL instrument. This subcontract is issued by the Department of Veterans Affairs through the 257-NETWORK Contract Office 17, with performance required in Dallas, Texas, at ZIP code 75216. The reagents must meet stringent regulatory standards and be compatible with the specified diagnostic platform to ensure accurate and reliable results in clinical settings. The solicitation was posted on August 3, 2026, and responses are due by August 10, 2026, at 3:00 PM local time. The NAICS code 325414 identifies this as a business involved in the manufacturing of in vitro diagnostic substances. All reagents must be approved by the FDA and certified for use in tuberculosis screening programs within VA healthcare facilities.

257-NETWORK Contract Office 17 (36C257)

POSTED

DEADLINE

Supply of Multi-Level Quality Controls – TRICONTROL

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Reagent Supply – i-STAT CHEM8 Cartridges

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Reagent Supply – i-STAT CG4 Cartridges

Great Plains Area Indian Health Svc

POSTED

DEADLINE

Medical Diagnostic Test Kit SupplyThe contract seeks the supply of ready-to-use Salmonella Identification Test Kits designed for rapid, accurate detection in medical and public health settings. All kits must include complete components necessary for deployment and operation, with strict adherence to applicable regulatory standards to ensure reliability, safety, and consistency across use environments. The testing technology must meet established performance criteria for sensitivity, specificity, and stability under operational conditions, with documentation to verify compliance with relevant quality and regulatory frameworks. The contract is issued as a subcontract under the Department of Defense’s Medical Supply Chain initiative, with performance requirements tied to the designated location in Williamsburg, Virginia, at zip code 23185-5830. The solicitation is open for responses until August 10, 2026, and is classified under NAICS code 325414, which covers the manufacturing of diagnostic substances. The contracting activity is managed by the MEDICAL SUPPLY CHAIN MD SURG FSF, and interested parties must submit proposals through the DIBBS platform prior to the deadline to be considered for award.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Small Business Subcontract Participation (WOSB, SDVOSB, HUBZone)Certified small businesses including Women-Owned Small Businesses, Service-Disabled Veteran-Owned Small Businesses, and HUBZone concerns are invited to participate as subcontractors in supply, compliance, or logistics functions under a federal opportunity managed by the Department of Defense's Medical Supply Chain MD SURG FSF. This solicitation is tied to NAICS code 325414, indicating involvement in pharmaceutical and medicine manufacturing supply chain activities, and is specifically designed to foster small business engagement through subcontracting roles. The opportunity was posted on August 2, 2026, and responses are due by August 10, 2026, with no formal set-aside designation applied, allowing eligible small businesses to compete for subcontracting opportunities across the broader contract performance landscape. All participation must occur through the designated DIBBS platform linked in the solicitation, and while specific location details for performance are not provided, work will support Department of Defense medical supply needs.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Anesthesia Set SupplyThe contract entails the supply of complete epidural anesthesia kits, each comprising 29 precisely specified components, including a 20G epidural catheter and a 17G Tuohy needle featuring a winged design for enhanced handling and stability during insertion. The kits are intended for use in medical procedures requiring regional anesthesia and must meet strict quality and compatibility standards to ensure clinical safety and effectiveness. The solicitation is issued as a subcontract under the NAICS code 325414, which pertains to pharmaceutical and medicine manufacturing, and is managed by the Department of Defense through its Medical Supply Chain MD Surg FSF division. Responses are due by August 10, 2026, with the request published on August 2, 2026, providing potential suppliers a window of eight days to submit proposals. The place of performance and point of contact details are not specified, but all work is expected to align with Department of Defense procurement protocols and logistical requirements. The official solicitation can be accessed via the DIBBS platform for further technical specifications and submission guidelines.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Device Component Supply (6 mm Cannula and 60 cc Syringe)The contract requires the supply of sterile, medical-grade 6 mm cannulas and 60 cc syringes to be integrated into an aspiration kit, with all components meeting stringent FDA and military specifications to ensure safety, sterility, and regulatory compliance. These components are critical for use in field-deployed medical environments and must be manufactured and packaged to uphold the highest standards of quality and reliability under demanding operational conditions. The delivery must align with military logistics requirements, including packaging, labeling, and traceability protocols appropriate for DoD procurement. The solicitation is issued under the NAICS code 325414 for medical device manufacturing and is classified as a subcontract within the Department of Defense's Medical Supply Chain initiative. The place of performance is designated as APO 96264-2022, indicating delivery to a military postal address, likely for distribution to overseas or expeditionary medical units. The response deadline is set for August 10, 2026, with the solicitation posted on August 2, 2026, providing a seven-day window for qualified suppliers to submit proposals. No set-aside provisions are specified, meaning the opportunity is open to all eligible contractors capable of fulfilling the technical and regulatory demands.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Sterile Medical Kit Assembly and PackagingThe contract seeks the manufacture and sterile packaging of a uterine vacuum extractor aspiration kit, which includes a 60 cc syringe and a 6 mm cannula, meeting strict military medical packaging and labeling standards. All components must be produced under sterile conditions and assembled into a final kit that adheres to Department of Defense specifications for field use, ensuring readiness and compliance in operational environments. The packaging must maintain sterility through transit and storage, with labeling conforming to military requirements for identification, handling, and traceability. Performance is required at APO ZIP 96264-2022, with responses due by August 10, 2026, and the solicitation posted on August 2, 2026. This is a subcontract opportunity under NAICS code 325414, which pertains to pharmaceutical and biological product manufacturing. The contracting entity is the Medical Supply Chain MD Surg FSF within the Department of Defense, indicating the end-user is a military medical logistics division. Successful bidders must demonstrate capability in sterile medical device assembly and compliance with defense-specific packaging regulations to ensure operational reliability in austere conditions.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Product Supplier (OEM or Distributor)The contract requires suppliers to provide FDA-compliant, latex-free, hydrophilic gel adhesive occlusive chest wound seal dressings that meet military specifications, targeting combat and emergency medical use. These dressings must be engineered for rapid deployment, effective wound sealing, and compatibility with harsh field conditions, ensuring optimal performance in military trauma scenarios. The product must adhere to strict regulatory and performance standards to qualify for procurement by the Department of Defense. The solicitation is issued as a subcontract under the NAICS code 325414, with a response deadline of August 10, 2026, and a posted date of August 2, 2026. Performance of the contract is tied to Tinker Air Force Base, Oklahoma, with delivery and compliance expectations aligned to military medical supply chain protocols. The procuring entity, Medical Supply Chain MD Surg FSF, acts on behalf of the Department of Defense, seeking qualified OEMs or distributors capable of consistent, high-volume production and reliable logistics support under federal medical procurement guidelines.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Small Business Subcontracting Participation (Post-Award)The contract opportunity is designated for small, disadvantaged, and socioeconomically certified businesses seeking post-award subcontracting roles within the Medical Supply Chain under the Department of Defense. It pertains to the NAICS code 325414, which corresponds to the manufacture of pharmaceutical and medicine products, suggesting a focus on medical supplies and surgical support systems. The opportunity is open for submissions from qualified businesses with a response deadline of August 10, 2026, and was posted on August 2, 2026. Performance will be centered at FPO with a ZIP code of 96694, indicating a military postal address likely tied to overseas or expeditionary operations. This subcontracting initiative aims to increase participation from certified small businesses in the defense medical supply ecosystem, fostering diversity and resilience in critical supply chains without specifying a formal set-aside classification. Interested parties must engage through the official DIBBS portal using the provided link to submit proposals or obtain further details.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Medical Specimen Collection Kit SupplyThe contract solicits the supply of bacteriological specimen collection and transportation systems equipped with transport media, designed to meet stringent military and medical packaging standards. These systems must ensure the safe, secure, and compliant handling of biological samples under operational conditions, accommodating the demanding requirements of field medical units and deployed forces. The equipment must maintain specimen integrity during transport, resisting environmental variables such as temperature fluctuations, vibration, and physical impact, while adhering to all regulatory and safety protocols for biological materials. The solicitation, issued under NAICS code 325414 for pharmaceutical and biological product manufacturing, is classified as a subcontract opportunity with a response deadline of August 10, 2026. Performance will be directed to FPO, ZIP 96694, indicating delivery to military postal locations, likely supporting expeditionary or overseas operations. The contracting entity is the Department of Defense through the Medical Supply Chain MD Surg FSF, underscoring the critical role this procurement plays in sustaining health and medical readiness within military operations. All submissions must fully comply with technical specifications for packaging, labeling, and transport media composition to guarantee operational effectiveness and regulatory compliance.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE

Small Business Subcontracting & Accelerated PaymentsSmall businesses are invited to serve as subcontractors under a federal procurement opportunity tied to the Medical Supply Chain MD Surg FSF, part of the Department of Defense, with performance centered at Fort Stewart, Georgia, ZIP 31314-5185. This opportunity leverages FAR 52.232-40 to enable accelerated payments to qualifying small business subcontractors, offering improved cash flow and financial stability during contract execution. The NAICS code 325414 indicates the work involves manufacturing pharmaceutical preparations, suggesting the subcontract work likely supports medical product supply chains for defense healthcare needs. The solicitation is open for response until August 10, 2026, with no set-aside designation specified, meaning competition is open to all eligible small businesses regardless of size category or demographic criteria. Interested parties must register via the provided DIBBS link to access full details and submit proposals.

MEDICAL SUPPLY CHAIN MD SURG FSF

POSTED

DEADLINE